CTX-2026
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer[1].
Product Specifications
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-2026.html
Purity
98.95
Solubility
10 mM in DMSO
Smiles
[3H][C][X2026]
Molecular Weight
(145.28 kDa)
References & Citations
[1]Payne KK, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science. 2020 Aug 21;369 (6506) :942-949.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1248739-01 1 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Putative multidrug resistance protein MdtD (mdtD), partial
Ask
View Details 
MBS1248739-02 1 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Putative multidrug resistance protein MdtD (mdtD), partial
Ask
View Details 